AT364095B - Verfahren zur herstellung neuer peptidderivate - Google Patents

Verfahren zur herstellung neuer peptidderivate

Info

Publication number
AT364095B
AT364095B AT0445178A AT445178A AT364095B AT 364095 B AT364095 B AT 364095B AT 0445178 A AT0445178 A AT 0445178A AT 445178 A AT445178 A AT 445178A AT 364095 B AT364095 B AT 364095B
Authority
AT
Austria
Prior art keywords
peptide derivatives
producing new
new peptide
producing
derivatives
Prior art date
Application number
AT0445178A
Other languages
German (de)
English (en)
Other versions
ATA445178A (de
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Priority to AT437880A priority Critical patent/AT398765B/de
Publication of ATA445178A publication Critical patent/ATA445178A/de
Application granted granted Critical
Publication of AT364095B publication Critical patent/AT364095B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069Ser-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT0445178A 1977-06-20 1978-06-19 Verfahren zur herstellung neuer peptidderivate AT364095B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT437880A AT398765B (de) 1977-06-20 1980-08-29 Verfahren zur herstellung von neuen lipopeptiden

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77584 1977-06-20

Publications (2)

Publication Number Publication Date
ATA445178A ATA445178A (de) 1981-02-15
AT364095B true AT364095B (de) 1981-09-25

Family

ID=19728618

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0445178A AT364095B (de) 1977-06-20 1978-06-19 Verfahren zur herstellung neuer peptidderivate

Country Status (18)

Country Link
EP (1) EP0000330B1 (fr)
JP (2) JPS549224A (fr)
AT (1) AT364095B (fr)
AU (1) AU525005B2 (fr)
CA (1) CA1139305A (fr)
DD (1) DD139257A5 (fr)
DE (1) DE2860893D1 (fr)
DK (1) DK275178A (fr)
ES (3) ES470961A1 (fr)
FI (1) FI781933A (fr)
GR (1) GR71681B (fr)
IE (1) IE46957B1 (fr)
IL (1) IL54950A (fr)
NO (1) NO148921C (fr)
NZ (1) NZ187611A (fr)
PL (3) PL216739A1 (fr)
PT (1) PT68188A (fr)
ZA (1) ZA783504B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014815A3 (fr) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Dérivés peptidiques, procédé pour leur préparation et intermédiaires, et compositions pharmaceutiques contenant un de ces composés
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
EP0306912A3 (fr) * 1987-09-08 1989-07-05 Albany Medical College Ensemble immunogène capable de provoquer sélectivement la production d'anticorps et compositions pharmaceutiques l'utilisant.
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
ES2096064T3 (es) * 1991-12-19 1997-03-01 Ciba Geigy Ag Derivados del acido aminosulfonico y procedimiento para su obtencion.
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
EP0604945A1 (fr) 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, dérivés, préparation et utilisation
EP0641776A3 (fr) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Dérivés de thioglycérol.
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
FR2816060A1 (fr) * 2000-10-27 2002-05-03 Pf Medicament Procede d'identification de nouvelles molecules se liant au recepteur lox et utilisation de ces molecules
EA014644B1 (ru) 2005-06-13 2010-12-30 Кливлэнд Биолабс Инк. Способы защиты от апоптоза с применением липопептидов
EP1909813A4 (fr) * 2005-07-25 2009-09-09 Therimunex Llc Diacylglycerides peptidyle
DE102016005550A1 (de) 2016-05-09 2017-11-09 Emc Microcollections Gmbh Adjuvans zur lnduzierung einer zellulären lmmunantwort
MX2020004742A (es) * 2017-11-06 2020-08-13 Crown Equip Corp Sistema de colocacion lateral de vehiculo industrial.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2706490A1 (de) 1976-02-20 1977-08-25 Ciba Geigy Ag Neue carbonsaeureester

Also Published As

Publication number Publication date
NO148921C (no) 1984-01-11
DE2860893D1 (en) 1981-11-05
FI781933A (fi) 1978-12-21
ZA783504B (en) 1979-06-27
ATA445178A (de) 1981-02-15
GR71681B (fr) 1983-06-21
PL216739A1 (fr) 1980-05-19
NO782138L (no) 1978-12-21
IE46957B1 (en) 1983-11-16
ES470961A1 (es) 1980-03-01
PL216740A1 (fr) 1980-05-19
ES478717A1 (es) 1979-12-16
JPS549224A (en) 1979-01-24
JPS6372671A (ja) 1988-04-02
IL54950A (en) 1983-10-31
IL54950A0 (en) 1978-08-31
CA1139305A (fr) 1983-01-11
PT68188A (de) 1978-07-01
JPS6360760B2 (fr) 1988-11-25
AU3723078A (en) 1980-01-03
EP0000330A1 (fr) 1979-01-24
IE781227L (en) 1978-12-20
PL207766A1 (pl) 1979-11-19
NO148921B (no) 1983-10-03
JPS641466B2 (fr) 1989-01-11
EP0000330B1 (fr) 1981-08-05
ES478718A1 (es) 1979-12-16
AU525005B2 (en) 1982-10-14
NZ187611A (en) 1981-07-13
DD139257A5 (de) 1979-12-19
DK275178A (da) 1978-12-21

Similar Documents

Publication Publication Date Title
AT359217B (de) Verfahren zur herstellung neuer peptid-derivate
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
AT364095B (de) Verfahren zur herstellung neuer peptidderivate
AT368755B (de) Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate
LU79235A1 (de) Verfahren zur herstellung neuer pyridinyl-aminoalkylaethern
ATA60577A (de) Verfahren zur herstellung neuer polypeptidderivate
AT360553B (de) Verfahren zur herstellung neuer nitroso- harnstoffverbindungen
AT367403B (de) Verfahren zur herstellung neuer chinolin-2onderivate
AT358601B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
AT363086B (de) Verfahren zur herstellung neuer benzopyranderivate
DD138211A5 (de) Verfahren zur herstellung neuer aminopyrimidin-verbindungen
ATA90478A (de) Verfahren zur herstellung neuer everninomicin- derivate
AT361640B (de) Verfahren zur herstellung neuer 3beta-substi- tuierter 18-beta-olean-9-en-30-oylsaeure- derivate
AT356294B (de) Verfahren zur herstellung neuer ergolinderivate
AT360998B (de) Verfahren zur herstellung neuer n-pyrimidinyl- -imidsaeureester
AT362063B (de) Verfahren zur herstellung neuer spectinomycin- derivate
AT380014B (de) Verfahren zur herstellung neuer oxazolidin-2-on- derivate
DD134765A5 (de) Verfahren zur herstellung neuer indolylglyoxylsaeurederivate
ATA590179A (de) Verfahren zur herstellung neuer 2-aminotetraline
AT373240B (de) Verfahren zur herstellung neuer pyridyloxyphenoxyalkancarbonsaeurederivate
ATA153980A (de) Verfahren zur herstellung neuer 3-oxaloamino-4- oxo-4h-1-benzopyranderivate
ATA269880A (de) Verfahren zur herstellung neuer pyridinderivate
ATA583379A (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
ATA464778A (de) Verfahren zur herstellung neuer indanderivate
AT367767B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate

Legal Events

Date Code Title Description
ELA Expired due to lapse of time